Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Animal Models

CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice

Abstract

Background/objectives:

Lymphocytes have a critical role in visceral adipose tissue (AT) inflammation. The CD28 costimulatory molecule is required for lymphocyte activation and for the development of a functional regulatory T cells (Tregs) compartment; however, its role during obesity is unknown.

Methods:

During diet-induced obesity, we investigated the effects of selective interference with CD28 signaling using knockout mice (Cd28KO) and a CTLA4-Ig fusion protein inhibiting CD28-B7 interactions.

Results:

Cd28 deficiency decreased pathogenic T cells and Treg content within AT without changing the macrophages number. Cd28KO epididymal but not subcutaneous fat was characterized by enlarged adipocytes, reduced levels of inflammatory cytokines and increased Glut4, adiponectin and lipogenic enzyme mRNA levels. This was associated with reduced inflammation, fat accumulation and enhanced glucose metabolism in liver. Weight gain and fasting glucose tolerance were not affected. CTLA4-Ig injections reduced the number of T cells in epididymal AT (epiAT) but not the inflammatory cytokines levels and failed to improve liver fat accumulation.

Conclusions:

Deletion of CD28 creates a new pro/anti-inflammatory balance in epiAT and liver and exerts a protective effect against hepatic steatosis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Hotamisligil GS . Inflammation and metabolic disorders. Nature 2006; 444: 860–867.

    Article  CAS  Google Scholar 

  2. Shoelson SE, Lee J, Goldfine AB . Inflammation and insulin resistance. J Clin Invest 2006; 116: 1793–1801.

    Article  CAS  Google Scholar 

  3. Chawla A, Nguyen KD, Goh YP . Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol 2011; 11: 738–749.

    Article  CAS  Google Scholar 

  4. Chatzigeorgiou A, Karalis KP, Bornstein SR, Chavakis T . Lymphocytes in obesity-related adipose tissue inflammation. Diabetologia 2012; 55: 2583–2592.

    Article  CAS  Google Scholar 

  5. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, Ohsugi M et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 2009; 15: 914–920.

    Article  CAS  Google Scholar 

  6. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, Nayer A et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 2009; 15: 930–939.

    Article  CAS  Google Scholar 

  7. Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D et al. Obesity predisposes to Th17 bias. Eur J Immunol 2009; 39: 2629–2635.

    Article  CAS  Google Scholar 

  8. Greenwald RJ, Freeman GJ, Sharpe AH . The B7 family revisited. Annu Rev Immunol 2005; 23: 515–548.

    Article  Google Scholar 

  9. Shahinian A, Pfeffer K, Lee KP, Kundig TM, Kishihara K, Wakeham A et al. Differential T cell costimulatory requirements in CD28-deficient mice. Science 1993; 261: 609–612.

    Article  CAS  Google Scholar 

  10. Green JM, Noel PJ, Sperling AI, Walunas TL, Gray GS, Bluestone JA et al. Absence of B7-dependent responses in CD28-deficient mice. Immunity 1994; 1: 501–508.

    Article  CAS  Google Scholar 

  11. Tai X, Cowan M, Feigenbaum L, Singer A . CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2. Nat Immunol 2005; 6: 152–162.

    Article  CAS  Google Scholar 

  12. Zhong J, Rao X, Braunstein Z, Taylor A, Narula V, Hazey J et al. T cell costimulation protects obesity-induced adipose inflammation and insulin resistance. Diabetes 2013; 63: 1289–1302.

    Article  Google Scholar 

  13. Chatzigeorgiou A, Chung KJ, Garcia-Martin R, Alexaki VI, Klotzsche-von Ameln A, Phieler J et al. Dual role of B7 costimulation in obesity-related non-alcoholic steatohepatitis (NASH) and metabolic dysregulation. Hepatology 2014; 60: 1196–1210.

    Article  CAS  Google Scholar 

  14. Honstettre A, Meghari S, Nunes JA, Lepidi H, Raoult D, Olive D et al. Role for the CD28 molecule in the control of Coxiella burnetii infection. Infect Immun 2006; 74: 1800–1808.

    Article  CAS  Google Scholar 

  15. Amar J, Serino M, Lange C, Chabo C, Iacovoni J, Mondot S et al. Involvement of tissue bacteria in the onset of diabetes in humans: evidence for a concept. Diabetologia 2011; 54: 3055–3061.

    Article  CAS  Google Scholar 

  16. Folch J, Lees M, Sloane Stanley GH . A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957; 226: 497–509.

    CAS  Google Scholar 

  17. Poggi M, Engel D, Christ A, Beckers L, Wijnands E, Boon L et al. CD40L deficiency ameliorates adipose tissue inflammation and metabolic manifestations of obesity in mice. Arterioscler Thromb Vasc Biol 2011; 31: 2251–2260.

    Article  CAS  Google Scholar 

  18. Mirenda V, Jarmin SJ, David R, Dyson J, Scott D, Gu Y et al. Physiologic and aberrant regulation of memory T-cell trafficking by the costimulatory molecule CD28. Blood 2007; 109: 2968–2977.

    CAS  PubMed  Google Scholar 

  19. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, Wabitsch M et al. T-lymphocyte infiltration in visceral adipose tissue. A primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 2008; 28: 1304–1310.

    Article  CAS  Google Scholar 

  20. Duffaut C, Galitzky J, Lafontan M, Bouloumie A . Unexpected trafficking of immune cells within the adipose tissue during the onset of obesity. Biochem Biophys Res Commun 2009; 384: 482–485.

    Article  CAS  Google Scholar 

  21. Mantovani A, Biswas SK, Galdiero MR, Sica A, Locati M . Macrophage plasticity and polarization in tissue repair and remodelling. J Pathol 2012; 229: 176–185.

    Article  Google Scholar 

  22. Mantovani A, Garlanda C, Locati M . Macrophage diversity and polarization in atherosclerosis: a question of balance. Arterioscler Thromb Vasc Biol 2009; 29: 1419–1423.

    Article  CAS  Google Scholar 

  23. Winer S, Chan Y, Paltser G, Truong D, Tsui H, Bahrami J et al. Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 2009; 15: 921–929.

    Article  CAS  Google Scholar 

  24. Burcelin R, Serino M, Chabo C, Garidou L, Pomie C, Courtney M et al. Metagenome and metabolism: the tissue microbiota hypothesis. Diabetes Obes Metab 2013; 15: 61–70.

    Article  CAS  Google Scholar 

  25. Iynedjian PB . Molecular physiology of mammalian glucokinase. Cell Mol Life Sci 2009; 66: 27–42.

    Article  CAS  Google Scholar 

  26. Ursini F, Mauro D, Naty S, Gagliardi D, Grembiale RD . Improvement in insulin resistance after short-term treatment with abatacept: case report and short review. Clin Rheumatol 2012; 31: 1401–1402.

    Article  Google Scholar 

  27. Fujii M, Inoguchi T, Batchuluun B, Sugiyama N, Kobayashi K, Sonoda N et al. CTLA-4Ig immunotherapy of obesity-induced insulin resistance by manipulation of macrophage polarization in adipose tissues. Biochem Biophys Res Commun 2013; 438: 103–109.

    Article  CAS  Google Scholar 

  28. Montes VN, Turner MS, Subramanian S, Ding Y, Hayden-Ledbetter M, Slater S et al. T Cell Activation Inhibitors Reduce CD8+ T Cell and Pro-Inflammatory Macrophage Accumulation in Adipose Tissue of Obese Mice. PLoS One 2013; 8: e67709.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank V Ferrier-Depraetere (Institut Paoli-Calmettes) for thoughtful reading of the manuscript. We are grateful to P Guichard and P Gibier for their help in animal handling feeding and body weight monitoring; F Gianardi (inter-IFR animal facility) for taking care of the Cd28KO mouse colony and finally C Fossat, I Arnoux and the CRCM cytometry platform for FACS analysis. This work was supported by the “Societé Francophone du Diabète”, the European society of cardiology (grant to MP) and by the “Comité du Var de la Ligue contre le cancer” (to JAN). JA Nunès and D Olive laboratory is supported by the Fondation pour la Recherche Médicale (Equipe FRM DEQ20140329534). SO Morin is supported by a fellowship from Aix-Marseille Université. D Olive is a scholar of the Institut Universitaire de France.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Poggi.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on International Journal of Obesity website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poggi, M., Morin, S., Bastelica, D. et al. CD28 deletion improves obesity-induced liver steatosis but increases adiposity in mice. Int J Obes 39, 977–985 (2015). https://doi.org/10.1038/ijo.2015.26

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ijo.2015.26

This article is cited by

Search

Quick links